Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.

British journal of haematology - 1 Jul 2026

Marchisio Sara, Yakymiv Yuliya, Lin Liyun, Ortolan Erika, Pullano Verdiana, Ponti Renata, de Bie Fenna J, van der Sluijs-Gelling Alita J, Zoutman Willem H, Pala Valentina, Scheeren Ferenc A, Vermeer Maarten H, Funaro Ada, Quaglino Pietro, Roccuzzo Gabriele

Abstract excerpt

Sézary syndrome (SS) is an aggressive cutaneous T-cell lymphoma, characterized by erythroderma, lymphadenopathy and circulating malignant CD4+ T cells. Despite therapeutic advances, SS remains an incurable disease. Early diagnosis is therefore essential for timely therapeutic intervention; however, reliable biomarkers to identify circulating SS cells are still lacking. Recent studies highlighted dysregulation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5'-Nucleotidase
Share to ADP-ribosyl Cyclase 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens, CD

Share to Apyrase

Share to CD4-Positive T-Lymphocytes

Share to GPI-Linked Proteins

Share to Membrane Glycoproteins

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 42179066
DOI: 10.1111/bjh.70562
PMCID: PMC13340541

Genes

CD38
CD4
ENTPD1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.PMID 42179066Read ↗

Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndromeSemantic proximity Read ↗

CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndromeSemantic proximity Read ↗

Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomicsSemantic proximity Read ↗

Single-Cell Profiling Reveals Targetable Malignant T-Cell Subtypes and Immune Evasion Pathways in Sézary SyndromeSemantic proximity Read ↗

Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3Semantic proximity Read ↗

Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine.Semantic proximity Read ↗

Sézary syndrome: old enigmas, new targets.Semantic proximity Read ↗

MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndromeSemantic proximity Read ↗

Expression of CD164 on Malignant T cells in Sézary Syndrome.Semantic proximity Read ↗

Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived Sézary syndrome cells.Semantic proximity Read ↗

Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatmentSemantic proximity Read ↗

Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.